Future studies would involve in-depth isotope tracing studies on breast cancer cell lines and tissues to determine the contributions of glucose and glutamine to CCL2/CCR2- and MET-mediated metabolism during DCIS progression. This evidence concerns the gene CCL2 and breast cancer.